About: Ras Inhibition and the Survival Benefit Favoring Zoledronic Acid Compared With Denosumab in Patients With Multiple Myeloma Reply     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
rdfs:seeAlso
Description
  • The hypothesis put forward by Sorscher et al to explain survival differences in the subgroup of patients with multiple myeloma (MM) who were described in our article bears consideration, and the potential effect of zoledronic acid on survival in patients with MM and Ras mutation will require additional study.
  • The hypothesis put forward by Sorscher et al to explain survival differences in the subgroup of patients with multiple myeloma (MM) who were described in our article bears consideration, and the potential effect of zoledronic acid on survival in patients with MM and Ras mutation will require additional study. (en)
Title
  • Ras Inhibition and the Survival Benefit Favoring Zoledronic Acid Compared With Denosumab in Patients With Multiple Myeloma Reply
  • Ras Inhibition and the Survival Benefit Favoring Zoledronic Acid Compared With Denosumab in Patients With Multiple Myeloma Reply (en)
skos:prefLabel
  • Ras Inhibition and the Survival Benefit Favoring Zoledronic Acid Compared With Denosumab in Patients With Multiple Myeloma Reply
  • Ras Inhibition and the Survival Benefit Favoring Zoledronic Acid Compared With Denosumab in Patients With Multiple Myeloma Reply (en)
skos:notation
  • RIV/00064203:_____/11:7047!RIV12-MZ0-00064203
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • I
http://linked.open...iv/cisloPeriodika
  • 19
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 225721
http://linked.open...ai/riv/idVysledku
  • RIV/00064203:_____/11:7047
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • oncology; myeloma (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • US - Spojené státy americké
http://linked.open...ontrolniKodProRIV
  • [D2C97B1C13FB]
http://linked.open...i/riv/nazevZdroje
  • Journal of Clinical Oncology
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 29
http://linked.open...iv/tvurceVysledku
  • Prausová, Jana
  • Costa, L.
  • Dansey, R.
  • Goldwasser, F.
  • Henry, DH
  • Hirsh, V.
  • Hungria, V.
  • Jiang, Q.
  • Jun, S.
  • Scagliotti, G. V.
  • Sleeboom, H.
  • Spencer, A.
  • Vadhan-Raj, S.
  • Wang, JM
  • Willenbacher, W.
  • Yeh, H.
  • von Moos, R.
http://linked.open...ain/vavai/riv/wos
  • 000292210500035
issn
  • 0732-183X
number of pages
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 49 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software